Cargando…
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug cand...
Autores principales: | Ohashi, Hirofumi, Watashi, Koichi, Saso, Wakana, Shionoya, Kaho, Iwanami, Shoya, Hirokawa, Takatsugu, Shirai, Tsuyoshi, Kanaya, Shigehiko, Ito, Yusuke, Kim, Kwang Su, Nomura, Takao, Suzuki, Tateki, Nishioka, Kazane, Ando, Shuji, Ejima, Keisuke, Koizumi, Yoshiki, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Suzuki, Tadaki, Hashiguchi, Takao, Maenaka, Katsumi, Matano, Tetsuro, Muramatsu, Masamichi, Saijo, Masayuki, Aihara, Kazuyuki, Iwami, Shingo, Takeda, Makoto, McKeating, Jane A., Wakita, Takaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997640/ https://www.ncbi.nlm.nih.gov/pubmed/33817567 http://dx.doi.org/10.1016/j.isci.2021.102367 |
Ejemplares similares
-
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020) -
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021) -
Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
por: Hijikata, Atsushi, et al.
Publicado: (2021) -
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021) -
Revisiting the guidelines for ending isolation for COVID-19 patients
por: Jeong, Yong Dam, et al.
Publicado: (2021)